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Abstract
Mycoplasma contamination of cultured cell lines is a serious problem in research, altering cellular response to different
stimuli thus compromising experimental results. We found that chronic mycoplasma contamination of THP-1 cells
suppresses responses of THP-1 cells to TLR stimuli. For example, E. coli LPS induced IL-1 b was suppressed by 6 fold and IL-8
by 10 fold in mycoplasma positive THP-1 cells. Responses to live F. novicida challenge were suppressed by 50-fold and 40-
fold respectively for IL-1b and IL-8. Basal TLR4 expression level in THP-1 cells was decreased by mycoplasma by 2.4-fold
(p=0.0003). Importantly, cell responses to pathogen associated molecular patterns are completely restored by mycoplasma
clearance with Plasmocin. Thus, routine screening of cell lines for mycoplasma is important for the maintenance of reliable
experimental data and contaminated cell lines can be restored to their baseline function with antibiotic clearance of
mycoplasma.
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Introduction
Mycoplasma is a filterable bacteria which does not have a rigid
cell wall and is very resistant to a great number of antibiotics [1].
Mycoplasmal growth is rapid; and contamination of cultured
human cells by mycoplasma is a significant problem in
experimental research. Our study indicates that chronic myco-
plasma contamination of THP-1 cell cultures interferes with Toll-
like receptor (TLR) functions in response to a variety of pathogens
and toxins. Toll-like receptors (TLR) are pattern-recognition
receptors which affect gene transcription in response to a pathogen
associated molecular patterns (PAMP) like bacterial lipopolysac-
charide (LPS) [2,3]. TLR stimulation initiates a signal transduction
pathway which leads to the secretion of pro-inflammatory
cytokines such as IL-8 and IL-1b [4,5]. Many researchers report
that mycoplasmal PAMPs, like lipoproteins induce an inflamma-
tory response in primary monocytes and THP-1 cells in a way
similar to LPS [6,7,8]. However, we show that chronic
contamination of THP-1 cells by mycoplasma suppresses the
pro-inflammatory cellular response to E. coli LPS and Francisella
novicida, and that this suppression can be corrected with antibiotic
clearance of mycoplasma.
Materials and Methods
Human monocytic THP-1 cell lines were cultured in RPMI
1640 (MediaTech, Inc) containing 10% fetal bovine serum
(endotoxin-free; Atlanta Biologicals) and 1% penicillin-streptomy-
cin solution (Invitrogen Life Technologies). Mycoplasma-positive
and negative THP-1 cells were stimulated either with E. coli LPS
(100 ng/ml) or Francisella novicida (strain JSG2401; U112) for
15 hours in antibiotics-free media. The release of IL-1b and IL-8
in the culture media was evaluated by ELISA developed in our
laboratory [9]. RNA was extracted using Trizol (Invitrogen Life
Technologies) and evaluated for gene expression using RT-qPCR
as described previously [10]. Briefly, the expression of the genes of
interest was calculated in relative copy numbers (RCN), which is
relative to the average expression value of two housekeeping genes.
Data were analyzed within one group and between two groups
using paired t-test. For all analyses, p,0.05 was considered to be
significant. To check for mycoplasmal contamination, genomic
DNA was isolated using a Puregen kit (Qiagen; Puregen
Accessories), and verified by PCR where a high quality genomic
DNA is an important factor. The combination of the following
three sets of primers allowed detection of most mycoplasma species
[11,12,13]: Myco-280 forward 59- gggagaaacaggattagataccct-39
and reverse 59-tgcaccatctgtcactctgttaacctc-39; Myco-500 forward
59-ggcgaatgggtgagtaacacg-39 and reverse; and Myco-717 forward
F: 59-actcctacgggaggcagcagta-39 and reverse 59-tgcaccatctgt-
cactctgtt-39. PCR conditions were 5 min 95uC and then 35 cycles
at 94uC for 15 s, at 60uC for 15 sec, and at 72 for uC for 15 sec.
To eliminate mycoplasma contamination, mycoplasma positive
THP-1 cells were treated with 25 mg/ml of Plasmocin (InvivoGen)
for three weeks. Aliquots were taken every three to four days for
detection of mycoplasma by PCR. When cells were confirmed to
be a mycoplasma negative, they were further maintained in RPMI
1640 media in the absence of Plasmocin.
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Some THP-1 cell passages from our laboratory showed no
response to TLR agonists like E. coli LPS, or F. novicida.T o
determine the mechanism for this anergy, we tested whether
these cells were mycoplasma contaminated by analyzing the cells
for mycoplasma DNA by PCR. We found that cells which
showed minimal responses in IL-1b or IL-8 release after addition
of LPS or F. novicida tested positive for mycoplasma. Because we
had created a number of unique THP-1 cells stably expressing
various genes, we were interested in removal of mycoplasma
rather than discarding those cell lines. Treatment of mycoplasma
positive cells with Plasmocin effectively removed the presence of
mycoplasma within 14 days (Figure 1). To determine if the
mycoplasma contamination was responsible for the anergy, we
treated mycoplasma negative THP-1 cells (from ATCC, lot
385653, or plasmocin-treated from our stock) and mycoplasma
positive THP-1 cells with LPS or F. novicida, and compared their
IL-1b and IL-8 RNA message expression and cytokines release in
cell culture media (Figure 2). We found that mycoplasma positive
cells showed significant decrease in mRNA expression in response
to both LPS and F. novicida (Figure 2). In contrast, removal of
mycoplasma with Plasmocin rendered samples fully responsive to
LPS and F. novicida (Figure 2). Since it is known that F. novicida is
detected by TLR2 [14] and LPS is sensed by TLR4 [15], so it is
likely that chronic mycoplasma infection affects TLR2 and TLR4
signaling pathways. In part, we tested such possibility by
screening gene expression patterns in mycoplasma negative and
Figure 1. Plasmocin-dependent removal of mycoplasmal
contamination of THP-1 cells. THP-1 cells, chronically infected with
mycoplasma, were treated with Plasmocin (25 mg/ml every 3 days) and
aliquots were taken every three to four days for detection of
mycoplasma by PCR. DNA from mycoplasma negative (2) and positive
(+) cells was served as control (Ctr).
doi:10.1371/journal.pone.0009900.g001
Figure 2. Chronic mycoplasma infection inhibits THP-1 cells response to PAMPs. THP-1 cells, mycoplasma negative (2), positive (+)o r
treated with Plasmocin and confirmed to be a mycoplasma negative (P) were stimulated either with E. coli LPS or F. novicida (F.n.) for 15 hours in
antibiotic-free media. Gene expression was measured in relative copy numbers (RCN) and cytokine concentration in ng/ml. Mycoplasma positive cells
show decrease in expression of IL-1b message (A) and mature cytokine release (B), as well as IL-8 mRNA expression (C) and protein release (D).
Mycoplasma removal restores cellular function to these PAMPs (P). Data are expressed as mean 6 SEM. n=4 for qPCR of THP-1 treated with LPS and
n=8 for all other samples.
doi:10.1371/journal.pone.0009900.g002
Mycoplasma Suppresses TLR
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gene expression for T L R 4 ,I L 1 R 2 ,I K B 1 Z ,a n dIL10.F u r t h e r -
more, LPS stimulation of mycoplasma positive THP-1 cells
showed significant suppression of the TLR4, IL1R2, and IL10
genes as compared to controls (Figure 3). The effect was even
more pronounced to Francusella challenge affecting IL1R2,
MYD88, NFKBIZ, NFKBIA, CASP1, TNF, IL10, and IL6
significantly. There was no difference between mycoplasma
negative and positive THP-1 cells for TLR2, RELA and IRAK1
genes expression (Figure 3).
Figure 3. Gene expression in mycoplasma negative and positive THP-1 cells stimulated with LPS or F. novicida. Mycoplasma negative
(Myco 2) and positive (Myco +) THP-1 cells were stimulated either with E. coli LPS or F. novicida (F.n.) for 15 hours in antibiotic-free media. Gene
expression was measured in relative copy numbers (RCN). Data are expressed as mean 6 SEM. n=6. Asterisk (*) represents a p value,0.05 in
comparison between two groups, to show significance of mycoplasma contamination.
doi:10.1371/journal.pone.0009900.g003
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stimulate TLR-mediated pro-inflammatory response [7,8]. This
is different from our observation and may be explained by the
phenomenon of ‘‘LPS tolerance’’– the transient unresponsiveness
of cells to LPS after repeated or prolonged stimulation with LPS
[16]. The effects of LPS tolerance include the inhibition of TLR
signaling by inducible negative regulators, the suppression of
production of pro-inflammatory cytokines such as TNF-a, IL-1b
and IL-8, and alterations of the TLR signaling complex [17]. LPS
tolerance has traditionally been viewed as a hypo-responsive state
of macrophages resulting from receptor desensitization [16].
Several groups have reported examples of pro- and anti-
inflammatory gene induction in tolerant macrophages [18,19],
and others have reported that pre-incubation with low doses of
LPS can cause changes in the intracellular signal transduction
pathway which may lead to hyposensitivity and LPS tolerance
[20]. In contrast, it has also been reported that the expression of
IL-1a and b mRNA is markedly reduced in cell cultures
contaminated by mycoplasma, which corresponds to our obser-
vations [1]. LPS tolerance may also be induced by mycoplasmal
lipopeptides that impair the MyD88-depending signaling by
inhibiting LPS-mediated activation of IL-1 receptor-associated
kinase (IRAK1) [21].
Of course the best way to eliminate mycoplasma contamination
is to discard contaminated cells. However, in some cases a valuable
cell line may require a treatment of mycoplasma contamination to
restore functionality. Our data show that chronic mycoplasma
infections suppress TLR function and that cell treatment with
Plasmocin (a combination of two bactericidal compounds) can
effectively remove mycoplasma contamination (as detected by
PCR) and restore the ability of cells to respond to PAMPs.
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